NCT03651713 is a NA clinical trial of GLU+EX in Endothelial Function, sponsored by University of Iowa.

Who is sponsoring NCT03651713?

NCT03651713 is sponsored by University of Iowa.

What drugs are being tested in NCT03651713?

Interventions in NCT03651713: GLU+EX, GLU.

What condition does NCT03651713 study?

NCT03651713 studies Endothelial Function, Hyperglycemia.

Is NCT03651713 still recruiting?

NCT03651713 is currently completed. Last updated 24 March 2020.

Last reviewed 2020-03-24 · How we verify

NCT03651713

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hyperglycemia, Exercise, and Endothelial Function

Completed NA Last updated 24 March 2020

What this trial tests

NA trial testing GLU+EX in Endothelial Function in 32 participants. Completed in 21 October 2019.

Timeline

15 October 2018

Primary endpoint
21 October 2019

21 October 2019

Quick facts

Lead sponsor	University of Iowa
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	32
Start date	15 October 2018
Primary completion	21 October 2019
Estimated completion	21 October 2019
Sites	1 location across United States

Drugs / interventions tested

GLU+EX
GLU

Conditions studied

Endothelial Function — all drugs for Endothelial Function →
Hyperglycemia — all drugs for Hyperglycemia →

Sponsor

University of Iowa

Who can join

Adults 18 to 35, male only, with Endothelial Function or Hyperglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is to determine if exercise preserves vascular function during hyperglycemia. All subjects will consume a sugary beverage three times daily for seven days. Subjects will be randomly assigned to either the glucose with (GLU+EX) or without (GLU) structured exercise group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Endothelial Function

Currently open trials in the same condition.

NCT06288828 — The Efficacy of Aerobic Exercise Training on Autonomic Nervous System and Endothelial Function in Patients with Compensa · NA · active not recruiting

Other University of Iowa trials

Trials by the same sponsor.

NCT07224269 — Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis · EARLY_PHASE1 · not yet recruiting
NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve · NA · recruiting
NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion · NA · recruiting
NCT06710119 — Effect of Custom Dynamic Orthoses on Forefoot Loading · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03651713 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Iowa
Last refreshed: 24 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03651713.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing